| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6015533 | Epilepsy Research | 2014 | 5 Pages |
Abstract
The KD is an effective and well-tolerated treatment option for patients with refractory SE. In patients with focal SE secondary to inflammatory or probably inflammatory diseases, the KD should be considered earlier in the course of the treatment.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Roberto Horacio Caraballo, Santiago Flesler, Marisa Armeno, Sebastian Fortini, Ariela Agustinho, Graciela Mestre, Araceli Cresta, MarÃa Celeste Buompadre, Nidia Escobal,